Ben Newman

Ben Newman is a seasoned professional in commercial operations with extensive experience in the biotechnology and pharmaceutical industries. Currently serving as Vice President of Commercial Operations at Intellia Therapeutics, Inc. since April 2025, Ben previously held the position of VP, Head of Commercial Operations at Corium from January 2020 to April 2025. Prior roles include Director of Commercial Operations at Servier following its acquisition of Shire Oncology, and various positions at Shire, where notable achievements included being a two-time President's Club Award winner. Earlier experience includes Senior Sales Representative at PerkinElmer and Sales & Marketing Associate at CEB. Ben holds a B.A. in American Cultural Studies from Bates College.